Drug intelligence / Profile preview

CAM360 AmnioGraft

Development stage
Unknown
Lead developer
BioTissue
Administration
Ophthalmic, Topical
01

Overview

CAM360 AmnioGraft is a hydrated, cryopreserved amniotic membrane allograft developed by BioTissue for the treatment of ocular surface diseases. Utilizing proprietary SteriTrek and CryoTek preservation technologies, the product is shelf-stable at room temperature and retains the bioactive HC-HA/PTX3 complex responsible for its therapeutic properties. It exerts anti-inflammatory, anti-scarring, and anti-angiogenic effects to support tissue repair and ocular surface regeneration. The membrane is ringless and designed to adhere to the ocular surface under a bandage contact lens, making it suitable for treating conditions such as mild to moderate dry eye disease, superficial punctate keratitis, and neurotrophic keratitis.

Brand names
CAM360CAM-360CAM 360CAM360 AmnioGraftCAM-360 AmnioGraftCAM 360 AmnioGraft
Other names
CAM 360CAM360CAM-360CAM360-BioTissue SurgicalCAM-360-BioTissue SurgicalCAM 360-BioTissue Surgical
02

Targets

TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on CAM360 AmnioGraft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAM360 AmnioGraft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call